(SAF) Safran - Ratings and Ratios
Engines, Landing Systems, Avionics, Interiors, Defense
Dividends
| Dividend Yield | 0.99% |
| Yield on Cost 5y | 2.53% |
| Yield CAGR 5y | 72.31% |
| Payout Consistency | 83.9% |
| Payout Ratio | 28.1% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 20.6% |
| Value at Risk 5%th | 33.7% |
| Relative Tail Risk | -0.55% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.30 |
| Alpha | 36.11 |
| CAGR/Max DD | 1.61 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.731 |
| Beta | 0.183 |
| Beta Downside | 0.324 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.09% |
| Mean DD | 3.03% |
| Median DD | 2.14% |
Description: SAF Safran December 02, 2025
Safran SA (Ticker SAF) operates globally across aerospace and defense, organized into three core segments: Aerospace Propulsion, Aircraft Equipment / Defense & Aerosystems, and Aircraft Interiors. The Propulsion segment supplies engines, gearboxes and related MRO services for commercial jets, military aircraft, helicopters and drones. The Equipment segment delivers landing-gear, brakes, nacelles, avionics, security systems, optronic sensors and associated MRO support. The Interiors segment designs and manufactures passenger-facing products such as seats, cabin equipment, galleys, lavatories and in-flight entertainment/connectivity solutions.
Key recent data points: • FY 2023 revenue reached €20.6 bn, with the Propulsion segment contributing roughly 55 % of sales. • The order backlog stood at €45 bn, providing multi-year visibility amid a rebound in commercial aircraft deliveries. • Operating margin improved to 9.3 % year-over-year, driven by higher engine-spare-parts sales and cost-discipline in the Interiors business. • Sector drivers include the post-COVID resurgence in airline traffic (global passenger-kilometers up ~15 % YoY), sustained defense-budget growth in Europe and the U.S., and the industry shift toward more electric and hybrid propulsion architectures, which could expand Safran’s aftermarket opportunities.
For a deeper, data-driven look at Safran’s valuation assumptions and scenario outcomes, the ValueRay platform offers a concise, analytical overview.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (5.96b TTM) > 0 and > 6% of Revenue (6% = 3.31b TTM) |
| FCFTA 0.13 (>2.0%) and ΔFCFTA 5.29pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -4.54% (prev -9.00%; Δ 4.47pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 9.56b > Net Income 5.96b (YES >=105%, WARN >=100%) |
| Net Debt (-1.59b) to EBITDA (7.98b) ratio: -0.20 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.93 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (417.9m) change vs 12m ago -3.82% (target <= -2.0% for YES) |
| Gross Margin 40.83% (prev 22.19%; Δ 18.64pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 105.6% (prev 64.69%; Δ 40.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 30.18 (EBITDA TTM 7.98b / Interest Expense TTM 168.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.91
| (A) -0.04 = (Total Current Assets 34.97b - Total Current Liabilities 37.47b) / Total Assets 56.09b |
| (B) 0.09 = Retained Earnings (Balance) 5.04b / Total Assets 56.09b |
| (C) 0.10 = EBIT TTM 5.07b / Avg Total Assets 52.18b |
| (D) 0.24 = Book Value of Equity 10.31b / Total Liabilities 42.31b |
| Total Rating: 0.91 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 84.98
| 1. Piotroski 8.0pt |
| 2. FCF Yield 6.06% |
| 3. FCF Margin 13.40% |
| 4. Debt/Equity 0.39 |
| 5. Debt/Ebitda -0.20 |
| 6. ROIC - WACC (= 23.57)% |
| 7. RoE 51.04% |
| 8. Rev. Trend 56.11% |
| 9. EPS Trend 29.36% |
What is the price of SAF shares?
Over the past week, the price has changed by -0.91%, over one month by -4.85%, over three months by +4.66% and over the past year by +44.40%.
Is SAF a buy, sell or hold?
What are the forecasts/targets for the SAF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 328.7 | 11.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 402.1 | 36.8% |
SAF Fundamental Data Overview December 05, 2025
Market Cap EUR = 123.73b (123.73b EUR * 1.0 EUR.EUR)
P/E Trailing = 28.7222
P/E Forward = 27.1739
P/S = 4.2118
P/B = 9.1515
P/EG = 1.6604
Beta = 0.902
Revenue TTM = 55.10b EUR
EBIT TTM = 5.07b EUR
EBITDA TTM = 7.98b EUR
Long Term Debt = 2.11b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.43b EUR (from shortTermDebt, last quarter)
Debt = 5.12b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.59b EUR (from netDebt column, last quarter)
Enterprise Value = 121.86b EUR (123.73b + Debt 5.12b - CCE 6.99b)
Interest Coverage Ratio = 30.18 (Ebit TTM 5.07b / Interest Expense TTM 168.0m)
FCF Yield = 6.06% (FCF TTM 7.39b / Enterprise Value 121.86b)
FCF Margin = 13.40% (FCF TTM 7.39b / Revenue TTM 55.10b)
Net Margin = 10.81% (Net Income TTM 5.96b / Revenue TTM 55.10b)
Gross Margin = 40.83% ((Revenue TTM 55.10b - Cost of Revenue TTM 32.61b) / Revenue TTM)
Gross Margin QoQ = 51.08% (prev 45.93%)
Tobins Q-Ratio = 2.17 (Enterprise Value 121.86b / Total Assets 56.09b)
Interest Expense / Debt = 1.09% (Interest Expense 56.0m / Debt 5.12b)
Taxrate = 28.71% (2.06b / 7.17b)
NOPAT = 3.61b (EBIT 5.07b * (1 - 28.71%))
Current Ratio = 0.93 (Total Current Assets 34.97b / Total Current Liabilities 37.47b)
Debt / Equity = 0.39 (Debt 5.12b / totalStockholderEquity, last quarter 13.22b)
Debt / EBITDA = -0.20 (Net Debt -1.59b / EBITDA 7.98b)
Debt / FCF = -0.22 (Net Debt -1.59b / FCF TTM 7.39b)
Total Stockholder Equity = 11.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.62% (Net Income 5.96b / Total Assets 56.09b)
RoE = 51.04% (Net Income TTM 5.96b / Total Stockholder Equity 11.68b)
RoCE = 36.78% (EBIT 5.07b / Capital Employed (Equity 11.68b + L.T.Debt 2.11b))
RoIC = 30.03% (NOPAT 3.61b / Invested Capital 12.04b)
WACC = 6.46% (E(123.73b)/V(128.85b) * Re(6.69%) + D(5.12b)/V(128.85b) * Rd(1.09%) * (1-Tc(0.29)))
Discount Rate = 6.69% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -1.15%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈5.95b ; Y1≈7.34b ; Y5≈12.53b
Fair Price DCF = 511.1 (DCF Value 213.12b / Shares Outstanding 417.0m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 29.36 | EPS CAGR: 5.02% | SUE: 0.0 | # QB: 0
Revenue Correlation: 56.11 | Revenue CAGR: 24.36% | SUE: 0.10 | # QB: 0
EPS next Year (2026-12-31): EPS=10.59 | Chg30d=-0.030 | Revisions Net=+6 | Growth EPS=+27.5% | Growth Revenue=+13.1%